US Stock MarketDetailed Quotes
CYTH Cyclo Therapeutics
- 1.300
- +0.090+7.44%
Close Apr 24 16:00 ET
- 1.250
- -0.050-3.85%
Post 19:30 ET
37.33MMarket Cap-1056P/E (TTM)
1.310High1.220Low21.10KVolume1.230Open1.210Pre Close26.90KTurnover0.13%Turnover RatioLossP/E (Static)28.72MShares2.57052wk High7.83P/B20.62MFloat Cap0.89252wk Low--Dividend TTM15.87MShs Float17.750Historical High--Div YieldTTM7.44%Amplitude0.670Historical Low1.274Avg Price1Lot Size
Cyclo Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.76%1.08M | 66.70%311.4K | 9.58%495.48K | -78.39%117.12K | -21.80%152.41K | -13.24%1.38M | -68.07%186.8K | 11.95%452.17K | 127.12%541.89K | -45.58%194.9K |
| Operating revenue | -21.76%1.08M | 66.70%311.4K | 9.58%495.48K | -78.39%117.12K | -21.80%152.41K | -13.24%1.38M | -68.07%186.8K | 11.95%452.17K | 127.12%541.89K | -45.58%194.9K |
| Cost of revenue | -39.27%84.37K | -1.72%15.5K | 17.36%38.77K | -72.97%19.91K | -38.07%10.2K | -10.99%138.93K | -77.04%15.77K | 45.70%33.03K | 144.27%73.67K | -52.41%16.46K |
| Gross profit | -19.79%992.04K | 73.01%295.9K | 8.96%456.71K | -79.24%97.21K | -20.30%142.22K | -13.49%1.24M | -66.88%171.04K | 9.94%419.14K | 124.64%468.22K | -44.85%178.44K |
| Operating expense | 24.89%21.04M | 15.45%5.94M | 11.92%5.22M | 20.54%4.73M | 65.42%5.15M | 7.33%16.85M | 56.44%5.14M | 10.08%4.67M | 3.03%3.92M | -28.62%3.11M |
| Selling and administrative expenses | -16.59%5.67M | -18.55%1.4M | -4.42%1.53M | -27.13%1.28M | -15.23%1.46M | 24.53%6.79M | 7.22%1.72M | -25.66%1.6M | 90.80%1.75M | 120.18%1.73M |
| -Selling and marketing expense | -70.12%3.9K | 11.44%1.38K | -40.99%1.3K | -92.10%403 | -81.88%819 | -28.77%13.06K | -90.59%1.24K | -6.86%2.2K | 298.20%5.1K | 198.74%4.52K |
| -General and administrative expense | -16.49%5.66M | -18.57%1.4M | -4.37%1.53M | -26.94%1.27M | -15.06%1.46M | 24.71%6.78M | 8.03%1.72M | -25.68%1.6M | 90.51%1.74M | 120.03%1.72M |
| Research and development costs | 57.58%14.18M | 30.12%4.14M | 21.46%3.47M | 69.13%3.17M | 213.47%3.4M | -1.68%9M | 125.18%3.18M | 55.42%2.86M | -29.10%1.87M | -66.73%1.08M |
| Depreciation amortization depletion | -1.05%19.28K | -1.05%4.82K | -6.04%4.82K | 1.65%4.82K | 1.65%4.82K | 15.77%19.48K | 15.76%4.87K | 21.92%5.13K | -2.51%4.74K | 33.55%4.74K |
| -Depreciation and amortization | -1.05%19.28K | -1.05%4.82K | -6.04%4.82K | 1.65%4.82K | 1.65%4.82K | 15.77%19.48K | 15.76%4.87K | 21.92%5.13K | -2.51%4.74K | 33.55%4.74K |
| Other operating expenses | 13.36%1.18M | 65.27%390.1K | 7.07%221.45K | -5.18%280K | -4.98%283.63K | -3.36%1.04M | -11.61%236.04K | -16.18%206.83K | 21.32%295.29K | -5.37%298.5K |
| Operating profit | -28.43%-20.05M | -13.47%-5.64M | -12.22%-4.77M | -34.05%-4.63M | -70.63%-5.01M | -9.42%-15.61M | -79.43%-4.97M | -10.09%-4.25M | 4.01%-3.46M | 27.32%-2.93M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -104.51%-7.25K | 101.46%114 | -340.31%-3.89K | -187.08%-3.51K | -99.97%47 | 967.76%160.73K | 62.88%-7.79K | 230.65%1.62K | 32.09%4.03K | 24,539.33%162.87K |
| Gain on sale of security | -158.08%-7.25K | -95.40%114 | -340.31%-3.89K | -187.08%-3.51K | -98.92%47 | 266.34%12.47K | 166.45%2.48K | 230.65%1.62K | 32.09%4.03K | 556.88%4.34K |
| Special income (charges) | --0 | --0 | --0 | --0 | --0 | 776.12%148.25K | 53.15%-10.27K | --0 | --0 | --158.52K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---158.52K | --0 | ---- | ---- | ---158.52K |
| -Write off | --0 | ---- | ---- | ---- | ---- | -53.15%10.27K | ---- | ---- | ---- | ---- |
| Income before tax | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M | -10.02%-4.25M | 4.04%-3.45M | 31.34%-2.77M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M | -10.02%-4.25M | 4.04%-3.45M | 31.34%-2.77M |
| Net income continuous Operations | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M | -10.02%-4.25M | 4.04%-3.45M | 31.34%-2.77M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M | -10.02%-4.25M | 4.04%-3.45M | 31.34%-2.77M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M | -10.02%-4.25M | 4.04%-3.45M | 31.34%-2.77M |
| Basic earnings per share | 32.79%-1.23 | 61.02%-0.23 | 42.00%-0.29 | 19.51%-0.33 | -39.39%-0.46 | 18.30%-1.83 | -73.53%-0.59 | 16.67%-0.5 | 26.79%-0.41 | 56.58%-0.33 |
| Diluted earnings per share | 32.79%-1.23 | 61.02%-0.23 | 42.00%-0.29 | 19.51%-0.33 | -39.39%-0.46 | 18.30%-1.83 | -73.53%-0.59 | 16.67%-0.5 | 26.79%-0.41 | 56.58%-0.33 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg